Hospital

The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.

Experts Review Updates on the Public Health Strategy for Monkeypox

November 30, 2022

Video

Although it has received less attention as flu season begins, public health experts are continuing to urge vaccination against monkeypox.

World AIDS Day Raises Awareness of Disparities, Barriers to HIV Care

November 30, 2022

Article

The 2022 theme is “Putting Ourselves to the Test: Achieving Equity to End HIV.”

Study Explores Challenges in Uptake of Long-Acting Injectable PrEP

November 30, 2022

Article

Challenges for uptake of long-acting injectable pre-exposure prophylaxis in populations at risk for HIV include fear of needles, potential adverse effects, and concerns about diminished efficacy.

5 Key Sessions and Interviews at the American Society of Health-System Pharmacists 2022 Midyear Clinical Meeting

November 30, 2022

Article

Pharmacy Times will be covering the American Society of Health-System Pharmacists 2022 Midyear Clinical Meeting from December 4 to 8.

Experimental Type 1 Diabetes Drug Could Slow Growth of Rare Mantle Cell Lymphoma

November 29, 2022

Article

An experimental drug could help scientists understand the development of mantle cell lymphoma and potentially increase overall survival.

Laugh Off Burnout? It May Not Be That Simple, But It Can Certainly Help

November 29, 2022

Article

Comedy has taught me several keys that have helped alleviate and manage burnout.

Infliximab Shows Promise Treating Psoriasis in Patients Undergoing Treatment With PD-1 Agents

November 29, 2022

Article

Treatment with immune checkpoint inhibitors have the potential for immune-related adverse events, such as psoriasis.

Derazantinib Shows Clinical Benefit, Manageable Safety Profile in Patients With Cholangiocarcinoma

November 29, 2022

Article

Derazantinib is an investigational oral inhibitor of FGFR1, FGFR2, and FGFR3 in patients with locally advanced or metastatic intrahepatic cholangiocarcinoma.

GSK Releases Positive Study Results for New First-in-Class Tuberculosis Drug

November 28, 2022

Article

GSK3036656 demonstrates early bactericidal activity with a low, once-daily oral dose after 14 days of treatment.

Nicotinamide Riboside May Increase Breast Cancer Risk, Metastasis

November 28, 2022

Article

Study suggests that high levels of nicotinamide riboside could increase the risk of developing triple-negative breast cancer and may cause the cancer to metastasize to the brain.